Treatment for Lung Cancer
Dear Alder Hey Children's NHS Foundation Trust,
The following question is being requested on behalf of Novartis. The purpose of these questions is to understand the variability of treatment within your trust and in context to
the rest of the country.
Q1. In the past 3 months (or the latest 3 months data you have available), how many metastatic non-small cell lung cancer (NSCLC) patients were treated with any of the following:
• Afatinib
• Alectinib
• Atezolizumab monotherapy
• Atezolizumab in combination
• Bevacizumab
• Brigatinib
• Capmatenib
• Ceritinib
• Crizotinib
• Dacomitinib
• Dabrafenib with Trametinib
• Docetaxel monotherapy
• Durvalumab
• Erlotinib
• Gefitinib
• Gemcitabine
• Nintedanib with Docetaxel
• Nivolumab
• Osimertinib
• Paclitaxel
• Pembrolizumab monotherapy
• Pembrolizumab in combination
• Pemetrexed with Carboplatin/Cisplatin
• Tepotinib
• Vinorelbine with Cisplatin/Carboplatin
• Any other SACT
• Palliative care only
Thank you for taking the time to answer this question and I look forward to hearing from you.
Yours faithfully,
Ben Holdsworth
Thank you for your email.
We are currently experiencing an extremely high volume of incoming
requests which may result in delays dealing with your email.
We will however aim to action emails at the earliest possible opportunity.
Emails regarding Freedom of Information Act requests should be sent to
[email address]
Dear Mr Holdsworth,
Thank you for your request for information under the Freedom of Information Act 2000.
Your request will be dealt with in line with Trust policy and national guidelines and a response will be sent to you in no more than 20 working days.
Regards
Information Governance Team
Alder Hey Children's NHS Foundation Trust
[Alder Hey Children's NHS Foundation Trust request email]
Dear Mr Holdsworth,
Please find attached a response to your recent Freedom of Information
request.
Regards
Information Governance Team
Alder Hey Children’s NHS Foundation Trust
Liverpool Heart & Chest Hospital NHS Foundation Trust
0151 600 1845
[1]signature_2121820037
References
Visible links
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now